An investigational red cell agglutination (RCA) test was evaluated for sensitivity in detecting and titering hepatitis B antigen (HB Ag) in comparison with two counterelectrophoresis (CEP) systems and a solid-phase radioimmunoassay (RIA). The RCA procedure was found to be significantly more sensitive than the CEP methods and compares favorably in sensitivity with the solid-phase RIA, detecting even lower concentrations of the HB Ag. Since the RCA test can be completed in 2 to 3 h and requires relatively inexpensive equipment, it offers a highly sensitive and rapid procedure suitable for use in blood banks to screen donors or detect low levels of antigen in serum of patients.
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The identification of Australia antigen or hepatitis B antigen (HB Ag) by Blumberg et al. (1) and its subsequent correlation with hepatitis (2) has allowed, for the first time, the screening of blood donors for potentially infectious blood. The methodology has ranged from Ouchterlony double diffusion (7) to counterelectrophoresis (CEP) (3) and radioimmunoassay (RIA) (4-6, 9) with RIA being described as the most sensitive method (4, 6) . However, RIA is not a practical procedure for many laboratories and requires at least an overnight incubation. A passive hemagglutination test described by Vyas et made with the diluting buffer supplied with the RCA system. In screening serums, 0.025 ml of sensitized cells are added to 0.025 ml of a test serum (1: 16); in titration of serums, serial dilutions of test material (0.025 ml) are prepared in a microtiter system using disposable "V" plates, and then the same volume of cells (0.025 ml) is added to each dilution. The plates are agitated on a Vortex mixer to afford uniform distribution of reagents within each well. The test is incubated for 2 h at room temperature and read for agglutination patterns. Serums showing positive agglutination at the 1:16 dilution in the screening procedure are confirmed by subsequent titration of the specimen. A duracyte control (0.25% unsensitized duracyte cells) is run with each serum along with a positive and negative control.
Radioimmunoassay. The Ausria-125 solid-phase radioimmunoassay of Abbott Laboratories was employed for testing of selected serum panels. The sera (0.1 ml) were added to polypropylene tubes coated with guinea pig HB Ab and then incubated for 16 h. Unbound antigen is removed by washing each tube five times with 2 ml of either tris(hydroxymethyl) aminomethane (Tris) buffer or sterile distilled water. This is followed by a second 90-min incubation after adding 0.1 ml of "25I-labeled HB Ab, thus creating an antibody-antigen-121I antibody "sandwich." The tubes again were rinsed as above to remove unbound label, and the radioactivity was determined in a gamma counter. With each unit of tests, seven negative and three positive controls were included to establish the mean and standard deviations. In these tests, the positive limit was defined as 2.1 times the mean count of the seven negative controls. Serums consistently giving a count in a range from 1.5 to 2.1 times the above mean value for negative controls are considered questionable, and for screening of donors the blood would not be used. Sensitivity in screening for HB Ag. To further evaluate the sensitivity of the RCA test for detecting HB Ag, the random population panels consisting of blood donors, hospital admissions, and laboratory personnel were tested by the RCA screening procedures and the AUS-tect CEP system. In addition, the Comparson with radioimmunoassay. The RCA procedure also was compared with the RIA test for detecting HB Ag in the screening of different serum panels. For this study, the second panel of 96 library sera and the hospitalized patient panel were tested by both screening techniques along with the AUS-tect CEP system. These results are summarized in Table 3 and show that HB Ag was detected in 34 of 156 sera by either the RCA or the RIA technique, whereas only 8 sera were positive by the CEP method. Of the 34 HB Ag-positive sera, 30 were detected by both RCA and RIA; two sera were positive by RCA and negative by RIA, whereas two were negative by RCA and positive by RIA. Therefore, both the RCA and RIA showed the same relative sensitivity for detecting HB Ag in screening tests with the serum panels from clinically ill and hospitalized patients.
Since the RCA and RIA procedures showed comparable results in detecting HB Ag in the panel sera by screening techniques, 25 HB Ag-positive serums were selected at random and tested to compare the absolute sensitivities between the two methods. A comparison of the end-point HB Ag titers of these sera determined by the RCA and RIA methods is summarized in Table 4 . The results show that the RCA titer is higher than the RIA titer for each of the 25 serums and suggests that the RCA test When the RCA test was compared with two CEP methods as to titers of antigen in known HB Ag-positive sera, the serums showed significantly higher antigen titers by RCA than with either of the two CEP procedures. In studies designed to test the ability of RCA to detect HB Ag-positive sera in comparison with CEP and solid-phase RIA, and RCA did not detect any additional positive sera over the CEP system in groups of 200 blood donors, 100 laboratory personnel, and 100 random hospital admissions. This is due, possibly, to the expected low incidence in "normal" populations, and much larger samples would be needed to detect a difference. In testing the AABB reference panel and selected hepatitisrelated sera, the RCA system detected more positive sera than either the AUS-tect or Hapindex CEP systems. On the other hand, the RCA and RIA tests appeared to be of similar sensitivity for detection of HB Ag in screening of sera. However, the RCA test may be capable of detecting even lower concentrations of HB Ag than theoretically could be present in apparently healthy blood donors whose sera still might be capable of transmitting hepatitis. By virtue of the fact more rapid results can be achieved using relatively inexpensive equipment, the RCA method offers a practical and highly sensitive means to screen blood donors for HB Ag and quantitate antigen in suspected patients. ACKNOWLEDGMENT This investigation was supported in part by a grant from The John A. Hartford Foundation, Inc., to the Baptist Memorial Hospital.
